51
|
Abstract
HERITABILITY INDICATORS: Genetic studies of tobacco use can be useful to understand the physiopathology of nicotine dependence and potentially to prevent it. Twin and adoption studies have clearly shown the role of genetic factors in tobacco use at different stages. Genetic factors account for 55% (range: 11-84%) of the smoking initiation and 61% (range: 52-71%) for persistence. Age at onset and intensity of smoking are also influenced by genetic factors. Estimation of the heritability of initiation/persistence of smoking varies by gender. It is estimated as 66%/61% for women and 49%/61% for men respectively. In adolescent twin studies, heritability estimated the liability of lifetime or current use of tobacco to be more than 80%, while the heritability for initiation being between 11% and 59%. Heavy smoking is also influenced by genetic factors, especially when patients are co-abusing alcohol or coffee. Genetics findings - Advances in molecular genetics identified different candidate genes for tobacco use mainly involving neurotransmission of neuromodulators. Because of the brain reward effects of nicotine on the mesolimbic system, the genes involved in the dopaminergic transmission receive specific attention. Genetic polymorphisms of the dopamine D1, D2, D4 and D5 receptors, dopamine transporter (DAT1) and dopamine B-hydroxylase (DBH) have been associated at least once with clinical aspects of tobacco use (initiation, dependence and intensity) and temperament traits as novelty seeking, the latter being lower in smokers and thus considered as a vulnerable marker in accordance with the reinforcement effect of nicotine. Regarding interaction between nicotine use and anxiety and depression, the gene encoding for the serotonin transporter (5-HTT) may constitute a candidate gene. Because of interindividual bioavailability of nicotine, genetic polymorphisms of metabolism enzymes have also been analysed. Some variants of the cytochrome P450 seem to be more frequent among dependent smokers than controls or ever smokers (CYP2A6) and heavier smokers (CYP2D6). Genetic research might be suitable for a therapeutic approach and identify subjects at high risk for nicotine dependence.
Collapse
Affiliation(s)
- N Hamdani
- INSERM U288, 91, boulevard de l'Hôpital, 75013 Paris
| | | | | |
Collapse
|
52
|
Gelernter J, Yu Y, Weiss R, Brady K, Panhuysen C, Yang BZ, Kranzler HR, Farrer L. Haplotype spanning TTC12 and ANKK1, flanked by the DRD2 and NCAM1 loci, is strongly associated to nicotine dependence in two distinct American populations. Hum Mol Genet 2006; 15:3498-507. [PMID: 17085484 DOI: 10.1093/hmg/ddl426] [Citation(s) in RCA: 142] [Impact Index Per Article: 7.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Nicotine dependence (ND) is a moderately heritable trait. We ascertained a set of 1615 subjects in 632 families [319 African-American (AA) and 313 European-American (EA)] based on affected sibling pairs with cocaine or opioid dependence. Subjects were interviewed with the Semi-Structured Assessment for Drug Dependence and Alcoholism (SSADDA). Previously, we identified a modest linkage peak (LOD score =1.97) for ND in the EA part of the sample on chromosome 11q23, a region that includes the NCAM1-TTC12-ANKK1-DRD2 gene cluster. DRD2 and NCAM1 are functional candidate genes for substance dependence; the TTC12 and ANKK1 loci are not well characterized. We genotyped a set of 43 single nucleotide polymorphisms (SNPs) spanning this region, and performed family-based association and haplotype analysis. There was relatively weak evidence for association of the flanking DRD2 and NCAM1 markers to ND, but very strong evidence of association of multiple SNPs at TTC12 and ANKK1 in both populations (minimal P=0.0007 in AAs and minimal P=0.00009 in EAs), and in the pooled sample, as well as strong evidence for highly significant association of a single haplotype spanning TTC12 and ANKK1 to ND in the pooled sample (P=0.0000001). We conclude that a risk locus for ND, important both in AAs and EAs, maps to a region that spans TTC12 and ANKK1. Functional studies of these loci are warranted. These results provide additional information useful in evaluating the many earlier discrepant findings regarding association of DRD2 with substance dependence.
Collapse
Affiliation(s)
- Joel Gelernter
- Division of Human Genetics, Department of Psychiatry, Yale University School of Medicine, West Haven, CT 06516, USA.
| | | | | | | | | | | | | | | |
Collapse
|
53
|
Li MD, Payne TJ, Ma JZ, Lou XY, Zhang D, Dupont RT, Crews KM, Somes G, Williams NJ, Elston RC. A genomewide search finds major susceptibility loci for nicotine dependence on chromosome 10 in African Americans. Am J Hum Genet 2006; 79:745-51. [PMID: 16960812 PMCID: PMC1592559 DOI: 10.1086/508208] [Citation(s) in RCA: 62] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2006] [Accepted: 07/28/2006] [Indexed: 12/11/2022] Open
Abstract
Epidemiological studies have demonstrated that genetic factors account for at least 50% of the liability for nicotine dependence (ND). Although several linkage studies have been conducted, all samples to date were primarily of European origin. In this study, we conducted a genomewide scan of 1,261 individuals, representing 402 nuclear families, of African American (AA) origin. We examined 385 autosomal microsatellite markers for ND, which was assessed by smoking quantity (SQ), the Heaviness of Smoking Index (HSI), and the Fagerstrom Test for ND (FTND). After performing linkage analyses using various methods implemented in the GENEHUNTER and S.A.G.E. programs, we found a region near marker D10S1432 on chromosome 10q22 that showed a significant linkage to indexed SQ, with a maximum LOD score of 4.17 at 92 cM and suggestive linkage to HSI, SQ, and log-transformed SQ. Additionally, we identified three regions that met the criteria for suggestive linkage to at least one ND measure: on chromosomes 9q31 at marker D9S1825, 11p11 between markers D11S1993 and D11S1344, and 13q13 between markers D13S325 and D13S788. Other locations on chromosomes 15p11, 17q25, and 18q12 exhibited some evidence of linkage for ND (LOD >1.44). The four regions with significant or suggestive linkage were positive for multiple ND measures by multiple statistical methods. Some of these regions have been linked to smoking behavior at nominally significant levels in other studies, which provides independent replication of the regions for ND in different cohorts. In summary, we found significant linkage on chromosome 10q22 and suggestive linkage on chromosomes 9, 11, and 13 for major genetic determinants of ND in an AA sample. Further analysis of these positive regions by fine mapping and/or association analysis is thus warranted. To our knowledge, this study represents the first genomewide linkage scan of ND in an AA sample.
Collapse
Affiliation(s)
- Ming D Li
- Department of Psychiatric Medicine, University of Virginia, Charlottesville, VA 22911, USA.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
54
|
Abstract
Classical genetic studies document strong complex genetic contributions to abuse of multiple addictive substances, to mnemonic processes that are likely to include those involved in substance dependence, and to the volumes of brain gray matter in regions that are likely to contribute to mnemonic/cognitive and to addictive processes. The working idea that these three heritable phenotypes are likely to share some of the same complex genetic underpinnings is presented. This review contains association-based molecular genetic studies of addiction that largely derive from my laboratory and their fit with linkage data from other laboratories. These combined results now identify many of the loci and genes that contain allelic variants that are likely to provide the heritable components of human addiction vulnerability. These data are also likely to have broad implications for neurotherapeutics. Drugs with potential abuse liabilities are widely used for indications that include pain, anxiety, sleep, seizure, and attentional disorders. There is increasing nonmedical use of these prescribed substances. Increasing information about addiction vulnerability gene variants should help to improve management of risks of dependence in individuals who receive such therapeutics. In addition, since mnemonic components that correlate well with individual differences in brain regional volumes are likely to play major roles in addiction processes, many addiction vulnerability genes are also good candidates to contribute to individual differences in mnemonic processes. Recently elucidation of addiction-associated haplotypes for the "cell adhesion" NrCAM gene illustrate several of these points.
Collapse
Affiliation(s)
- George R Uhl
- Molecular Neurobiology Branch, National Institute on Drug Abuse-Intramural Research Program, National Institutes of Health, Baltimore, Maryland, USA.
| |
Collapse
|
55
|
Lerer E, Kanyas K, Karni O, Ebstein RP, Lerer B. Why do young women smoke? II. Role of traumatic life experience, psychological characteristics and serotonergic genes. Mol Psychiatry 2006; 11:771-81. [PMID: 16770336 DOI: 10.1038/sj.mp.4001855] [Citation(s) in RCA: 37] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Cigarette smoking is a complex behavioral phenotype to which environmental, psychological and genetic factors contribute. The purpose of this study was to investigate these multifactorial effects with a specific focus on young women and on genes that encode serotonin (5-HT) receptors and the 5-HT transporter. A case-control sample of female Israeli college students provided comprehensive background data and details of cigarette smoking and completed a battery of psychological instruments. They were divided into smoking initiators (SI, n=242) or non-initiators (NI, n=148); SI were further subdivided into high (HND, n=127) and low nicotine-dependent smokers (LND, n=115) on the basis of their scores on the Fagerstrom Tolerance Questionnaire (FTQ). Single-nucleotide polymorphisms (SNPs) in five serotonin receptor genes (HTR1A, HTR1B, HTR2A, HTR2C and HTR6) and the 5-HT transporter-linked polymorphic region (5-HTTLPR) were genotyped. In a logistic regression model for SI (chi2=117.90, P=1.6 x 10(-19), Nagelkerke R2=0.42), novelty seeking (odds ratio (OR)=1.134, P=0.00009) was a significant risk factor. A five SNP CACCC haplotype in HTR6 was a strong protective factor against SI (OR=0.26; P=0.007). The interaction of HTR6-C276T genotype and lifetime traumatic experience contributed strongly to the risk of SI (OR=13.88, P=0.0001). Specifically, subjects homozygous for the HTR6-C276T C allele showed significantly increased risk of SI if they had experienced trauma. Although significant (chi2=42.85, P=1.00 x 10(-7)), the best-fitting model for ND was less predictive than the model for SI (Nagelkerke R2=0.24). HTR1B-G861C GG genotype (OR=2.29, P=0.01) was a significant risk factor for HND. Further studies should consider the interactive contribution of life events and relevant gene variants to cigarette smoking and other complex behavioral traits.
Collapse
MESH Headings
- Adult
- Case-Control Studies
- Female
- Haplotypes
- Humans
- Israel/epidemiology
- Life Change Events
- Logistic Models
- Personality
- Polymorphism, Single Nucleotide
- Receptor, Serotonin, 5-HT1A/genetics
- Receptor, Serotonin, 5-HT1B/genetics
- Receptor, Serotonin, 5-HT2A/genetics
- Receptor, Serotonin, 5-HT2C/genetics
- Receptors, Serotonin/genetics
- Risk Factors
- Smoking/epidemiology
- Smoking/genetics
- Smoking/psychology
Collapse
Affiliation(s)
- E Lerer
- Research Laboratory, Sara Herzog Memorial Hospital, Jerusalem, Israel.
| | | | | | | | | |
Collapse
|
56
|
Swan GE, Hops H, Wilhelmsen KC, Lessov-Schlaggar CN, Cheng LSC, Hudmon KS, Amos C, Feiler HS, Ring HZ, Andrews JA, Tildesley E, Benowitz N. A genome-wide screen for nicotine dependence susceptibility loci. Am J Med Genet B Neuropsychiatr Genet 2006; 141B:354-60. [PMID: 16671072 PMCID: PMC2563426 DOI: 10.1002/ajmg.b.30315] [Citation(s) in RCA: 51] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Genome-wide model free linkage analysis was conducted for nicotine dependence and tobacco use phenotypes in 607 members of 158 nuclear families consisting of at least two ever smokers (100 or more cigarettes smoked in lifetime). DNA from whole blood was genotyped for 739 autosomal microsatellite polymorphisms with an average inter-marker distance of 4.6 cM. A peak LOD score of 2.7 was observed on chromosome 6 for scores for the Fagerström Test for Nicotine Dependence. Exploratory analyses were conducted to determine whether sequence variation at other loci affected other measures of dependence or tobacco use. Four additional loci with LOD scores of 2.7 or more were associated with alternative measures of nicotine dependence, one with current frequency of use, and one with smoking cessation. Several of the corresponding support intervals were near putative loci reported previously (on chromosomes 6, 7, and 8) while others appear to be novel (on chromosomes 5, 16, and 19).
Collapse
Affiliation(s)
- Gary E. Swan
- Center for Health Sciences, SRI International, Menlo Park, California
| | - Hyman Hops
- Oregon Research Institute, Eugene, Oregon
| | - Kirk C. Wilhelmsen
- Departments of Neurology and Pharmacology, University of California, San Francisco
- Ernest Gallo Clinic and Research Center
| | | | | | - Karen S. Hudmon
- Center for Health Sciences, SRI International, Menlo Park, California
| | | | | | - Huijun Z. Ring
- Center for Health Sciences, SRI International, Menlo Park, California
| | | | | | - Neal Benowitz
- Division of Pharmacology University of California, San Francisco, San Francisco, California
| |
Collapse
|
57
|
Yu Y, Panhuysen C, Kranzler HR, Hesselbrock V, Rounsaville B, Weiss R, Brady K, Farrer LA, Gelernter J. Intronic variants in the dopa decarboxylase (
DDC
) gene are associated with smoking behavior in European-Americans and African-Americans. Hum Mol Genet 2006; 15:2192-9. [PMID: 16740595 DOI: 10.1093/hmg/ddl144] [Citation(s) in RCA: 39] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
We report here a study considering association of alleles and haplotypes at the DOPA decarboxylase (DDC) locus with the DSM-IV diagnosis of nicotine dependence (ND) or a quantitative measure for ND using the Fagerstrom Test for Nicotine Dependence (FTND). We genotyped 18 single nucleotide polymorphisms (SNPs) spanning a region of approximately 210 kb that includes DDC and the genes immediately flanking DDC in 1,590 individuals from 621 families of African-American (AA) or European-American (EA) ancestry. Evidence of association (family-based tests) was observed with several SNPs for both traits (0.0002<or=P<or=0.04). The most significant result was obtained for the relationship of FTND score to SNP rs12718541 (AA families: P=0.002; EA families: P=0.03; all families: P=0.0002) which is in the same intron as the splice site for a neuronal isoform of human DDC lacking exons 10-15. Haplotype analysis did not reveal any SNP combination with stronger evidence for association than rs12718541 alone. Although sequence analysis suggests that rs12718541 may be an intronic splicing enhancer, further studies are needed to determine whether a direct link exists between an alternatively spliced form of DDC and predisposition to ND. These findings confirm a previous report of association of DDC with ND, localize the causative variants to the 3' end of the coding region and extend the association to multiple population groups.
Collapse
Affiliation(s)
- Yi Yu
- Department of Medicine, Genetics Program, Boston University School of Medicine, MA, USA
| | | | | | | | | | | | | | | | | |
Collapse
|
58
|
Gelernter J, Panhuysen C, Wilcox M, Hesselbrock V, Rounsaville B, Poling J, Weiss R, Sonne S, Zhao H, Farrer L, Kranzler HR. Genomewide linkage scan for opioid dependence and related traits. Am J Hum Genet 2006; 78:759-769. [PMID: 16642432 PMCID: PMC1474044 DOI: 10.1086/503631] [Citation(s) in RCA: 120] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2005] [Accepted: 02/22/2006] [Indexed: 11/03/2022] Open
Abstract
Risk of opioid dependence is genetically influenced. We recruited a sample of 393 small nuclear families (including 250 full-sib and 46 half-sib pairs), each with at least one individual with opioid dependence. Subjects underwent a detailed evaluation of substance dependence-related traits. As planned a priori to reduce heterogeneity, we used cluster analytic methods to identify opioid dependence-related symptom clusters, which were shown to be heritable. We then completed a genomewide linkage scan (with 409 markers) for the opioid-dependence diagnosis and for the two cluster-defined phenotypes represented by >250 families: the heavy-opioid-use cluster and the non-opioid-use cluster. Further exploratory analyses were completed for the other cluster-defined phenotypes. The statistically strongest results were seen with the cluster-defined traits. For the heavy-opioid-use cluster, we observed a LOD score of 3.06 on chromosome 17 (empirical pointwise P = .0002) for European American (EA) and African American (AA) subjects combined, and, for the non-opioid-use cluster, we observed a LOD score of 3.46 elsewhere on chromosome 17 (empirical pointwise P = .00002, uncorrected for multiple traits studied) for EA subjects only. We also identified a possible linkage (LOD score 2.43) of opioid dependence with chromosome 2 markers for the AA subjects. These results are an initial step in identifying genes for opioid dependence on the basis of a genomewide investigation (i.e., a study not conditioned on prior physiological candidate-gene hypotheses).
Collapse
Affiliation(s)
- Joel Gelernter
- Division of Human Genetics, Department of Psychiatry, Yale University School of Medicine, New Haven; VA Connecticut Healthcare Center, West Haven.
| | - Carolien Panhuysen
- Genetics Program, Department of Medicine, Boston University School of Medicine, Boston; Department of Biostatistics, School of Public Health, Boston University School of Medicine, Boston
| | - Marsha Wilcox
- Genetics Program, Department of Medicine, Boston University School of Medicine, Boston; Department of Biostatistics, School of Public Health, Boston University School of Medicine, Boston
| | - Victor Hesselbrock
- Department of Psychiatry, University of Connecticut School of Medicine, Farmington
| | - Bruce Rounsaville
- Division of Human Genetics, Department of Psychiatry, Yale University School of Medicine, New Haven; VA Connecticut Healthcare Center, West Haven
| | - James Poling
- Division of Human Genetics, Department of Psychiatry, Yale University School of Medicine, New Haven; VA Connecticut Healthcare Center, West Haven
| | - Roger Weiss
- Department of Psychiatry, Harvard Medical School, Boston; Alcohol and Drug Abuse Treatment Program, McLean Hospital, Belmont, MA
| | - Susan Sonne
- Department of Psychiatry, Medical University of South Carolina, Charleston
| | - Hongyu Zhao
- Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven; Department of Genetics, Yale University School of Medicine, New Haven
| | - Lindsay Farrer
- Genetics Program, Department of Medicine, Boston University School of Medicine, Boston; Department of Biostatistics, School of Public Health, Boston University School of Medicine, Boston
| | - Henry R Kranzler
- Department of Psychiatry, University of Connecticut School of Medicine, Farmington
| |
Collapse
|
59
|
Abstract
Molecular genetic studies of personality began with two high impact papers in 1996 that showed provisional associations between the dopamine DRD4 exon III repeat region and Novelty Seeking/Extraversion. These first two reports were shortly followed by an investigation linking Neuroticism/Harm Avoidance with the serotonin transporter (SLC6A4) promoter region polymorphism (5-HTTLPR). In the ensuing decade, thousands of subjects have been studied for association between these genes and personality, assessed by using self-report questionnaires, with erratic success in replication of the first findings for Novelty Seeking (DRD4) and Harm Avoidance (5-HTTLPR). Small effect sizes characteristic of non-Mendelian traits, polygenic patterns of inheritance and true heterogeneity between studies confound attempts to reach a consensus regarding the role of common polymorphisms in contributing to personality domains. Nevertheless, the current state of personality genetics is far from being bleak. Several new paradigms especially functional neuroimaging or 'imaging genomics' have strengthened the connection between 5-HTTLPR and anxiety-related personality traits. The demonstrations that early environmental information can considerably strengthen and even uncover associations between genes and behavior (Caspi's seminal studies and more recently the demonstration that early environment impacts on DRD4 and Novelty Seeking) are notable and herald a new era of personality genetics. Finally, consideration of the broader phenotypic expression of common polymorphisms (e.g. the 'social brain', altruism, etc.) and the use of new experimental paradigms including neurophysiological, neuropsychological and computer games that go beyond the narrow self-report questionnaire design will enable a deeper understanding of how common genetic polymorphisms modulate human behavior. Human personality, defined by Webster as the quality or state of being a person or the complex of characteristics that distinguishes an individual, surely requires a more encompassing view towards understanding its complex molecular genetic architecture.
Collapse
Affiliation(s)
- R P Ebstein
- Department of Psychology and Scheinfeld Center for Genetic Studies in the Social Sciences, Mount Scopus, Hebrew University, Jerusalem, Israel.
| |
Collapse
|
60
|
Kaabi B, Gelernter J, Woods SW, Goddard A, Page GP, Elston RC. Genome scan for loci predisposing to anxiety disorders using a novel multivariate approach: strong evidence for a chromosome 4 risk locus. Am J Hum Genet 2006; 78:543-53. [PMID: 16532386 PMCID: PMC1424685 DOI: 10.1086/501072] [Citation(s) in RCA: 68] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2005] [Accepted: 01/10/2006] [Indexed: 12/21/2022] Open
Abstract
We conducted a 10-centimorgan linkage autosomal genome scan in a set of 19 extended American pedigrees (219 subjects) ascertained through probands with panic disorder. Several anxiety disorders--including social phobia, agoraphobia, and simple phobia--in addition to panic disorder segregate in these families. In previous studies of this sample, linkage analyses were based separately on each of the individual categorical affection diagnoses. Given the substantial comorbidity between anxiety disorders and their probable shared genetic liability, it is clear that this method discards a considerable amount of information. In this article, we propose a new approach that considers panic disorder, simple phobia, social phobia, and agoraphobia as expressions of the same multivariate, putatively genetically influenced trait. We applied the most powerful multipoint Haseman-Elston method, using the grade of membership score generated from a fuzzy clustering of these phenotypes as the dependent variable in Haseman-Elston regression. One region on chromosome 4q31-q34, at marker D4S413 (with multipoint and single-point nominal P values < .00001), showed strong evidence of linkage (genomewide significance at P<.05). The same region is known to be the site of a neuropeptide Y receptor gene, NPY1R (4q31-q32), that was recently connected to anxiolytic-like effects in rats. Several other regions on four chromosomes (4q21.21-22.3, 5q14.2-14.3, 8p23.1, and 14q22.3-23.3) met criteria for suggestive linkage (multipoint nominal P values < .01). Family-by-family analysis did not show any strong evidence of heterogeneity. Our findings support the notion that the major anxiety disorders, including phobias and panic disorder, are complex traits that share at least one susceptibility locus. This method could be applied to other complex traits for which shared genetic-liability factors are thought to be important, such as substance dependencies.
Collapse
Affiliation(s)
- Belhassen Kaabi
- Laboratory of Epidemiology and Ecology of Parasites, Institut Pasteur de Tunis, Tunis, Tunisia; Department of Psychiatry, Yale University School of Medicine, New Haven; Department of Psychiatry, VA Connecticut Healthcare System, West Haven, CT; Indiana University School of Medicine, Indianapolis; Department of Biostatistics, University of Alabama at Birmingham, Birmingham; and Department of Epidemiology and Biostatistics, School of Medicine, Case Western Reserve University, Cleveland
| | - Joel Gelernter
- Laboratory of Epidemiology and Ecology of Parasites, Institut Pasteur de Tunis, Tunis, Tunisia; Department of Psychiatry, Yale University School of Medicine, New Haven; Department of Psychiatry, VA Connecticut Healthcare System, West Haven, CT; Indiana University School of Medicine, Indianapolis; Department of Biostatistics, University of Alabama at Birmingham, Birmingham; and Department of Epidemiology and Biostatistics, School of Medicine, Case Western Reserve University, Cleveland
| | - Scott W. Woods
- Laboratory of Epidemiology and Ecology of Parasites, Institut Pasteur de Tunis, Tunis, Tunisia; Department of Psychiatry, Yale University School of Medicine, New Haven; Department of Psychiatry, VA Connecticut Healthcare System, West Haven, CT; Indiana University School of Medicine, Indianapolis; Department of Biostatistics, University of Alabama at Birmingham, Birmingham; and Department of Epidemiology and Biostatistics, School of Medicine, Case Western Reserve University, Cleveland
| | - Andrew Goddard
- Laboratory of Epidemiology and Ecology of Parasites, Institut Pasteur de Tunis, Tunis, Tunisia; Department of Psychiatry, Yale University School of Medicine, New Haven; Department of Psychiatry, VA Connecticut Healthcare System, West Haven, CT; Indiana University School of Medicine, Indianapolis; Department of Biostatistics, University of Alabama at Birmingham, Birmingham; and Department of Epidemiology and Biostatistics, School of Medicine, Case Western Reserve University, Cleveland
| | - Grier P. Page
- Laboratory of Epidemiology and Ecology of Parasites, Institut Pasteur de Tunis, Tunis, Tunisia; Department of Psychiatry, Yale University School of Medicine, New Haven; Department of Psychiatry, VA Connecticut Healthcare System, West Haven, CT; Indiana University School of Medicine, Indianapolis; Department of Biostatistics, University of Alabama at Birmingham, Birmingham; and Department of Epidemiology and Biostatistics, School of Medicine, Case Western Reserve University, Cleveland
| | - Robert C. Elston
- Laboratory of Epidemiology and Ecology of Parasites, Institut Pasteur de Tunis, Tunis, Tunisia; Department of Psychiatry, Yale University School of Medicine, New Haven; Department of Psychiatry, VA Connecticut Healthcare System, West Haven, CT; Indiana University School of Medicine, Indianapolis; Department of Biostatistics, University of Alabama at Birmingham, Birmingham; and Department of Epidemiology and Biostatistics, School of Medicine, Case Western Reserve University, Cleveland
| |
Collapse
|
61
|
Abstract
Despite almost two decades of intensive tobacco-control efforts, approximately 23% of American adults continue to smoke, and 13% are nicotine-dependent. Cigarette smoking is the greatest preventable cause of cancer, accounting for at least 30% of all cancer deaths and 87% of lung cancer deaths. Smoking behavior is influenced by both genetic and environmental factors. Many years of twin and adoption studies have demonstrated that the heritability of liability for nicotine dependence (ND) is at least 50%. During the past several years, significant efforts have been made to identify susceptibility genes for ND using both genome-wide linkage and association analysis approaches. It is expected that identification of susceptibility genes for ND will allow the development and tailoring of both prevention strategies for individuals at risk and effective treatment programs and medicines for individuals who use tobacco products. This review summarizes the recent progress in genetic studies of ND. As genotyping technology is being improved and well-characterized clinical samples on smoking behavior become available, more and more genes and genetic variants responsible for ND will be identified in the near future.
Collapse
Affiliation(s)
- Ming D Li
- Department of Psychiatric Medicine, University of Virginia, 1670 Discovery Drive, Suite 110, Charlottesville, VA 22911, USA.
| |
Collapse
|
62
|
Rodríguez S, Huang S, Chen XH, Gaunt TR, Syddall HE, Gilg JA, Miller GJ, Cooper CC, Cook DG, Whincup PH, Day INM. A study of TH01 and IGF2-INS-TH haplotypes in relation to smoking initiation in three independent surveys. Pharmacogenet Genomics 2006; 16:15-23. [PMID: 16344718 DOI: 10.1097/01.fpc.0000178314.48619.5f] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
OBJECTIVES Recent studies suggest an association between a microsatellite locus (TH01) located in intron 1 of the tyrosine hydroxylase gene (TH) and nicotine dependence. We aimed here to study whether both TH01 and haplotypes of the wider IGF2-INS-TH region influence initiation of regular smoking in current smokers. METHODS A total of 3637 individuals from three independent studies (two of adults and one of adolescents) were analysed in relation to the age of first regular smoking (AFRS). Haplotypes and genotypes were obtained for the polymorphisms TH01, IGF2 ApaI, INS HphI and DRD4 VNTR (48 bp)n. Association between IGF2-INS-TH haplotypes and AFRS was tested by a regression model. A genotype-based genetic model assuming additivity was followed in order to estimate the effect of individual loci. RESULTS Overall, no significant associations were found after correcting for multiple tests. However, an IGF2-INS-TH haplotype (*5) was found to be nominally associated with AFRS at younger ages in adult smokers. Analyses of individual loci points to TH01 as a possible candidate influencing initiation of regular smoking. An AFRS-lowering trend nominally associated with allele 9 in a dosage-dependent manner was identified in both adult cohorts. TH01 did not show association or trend with age of initiation (first puff) either in adolescents or in the adolescents smoking regularly at age 18. CONCLUSION This study adds to the genetic evaluation of the associations of TH01 with smoking predisposition. Differences between historical and prospective surveys, different biological pathways and possible functional roles of this microsatellite in smoking initiation are discussed.
Collapse
Affiliation(s)
- Santiago Rodríguez
- Human Genetics Division, University of Southampton School of Medicine, Southampton General Hospital, Tremona Road, Southampton, UK
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
63
|
Ehlers CL, Wilhelmsen KC. Genomic screen for loci associated with tobacco usage in Mission Indians. BMC MEDICAL GENETICS 2006; 7:9. [PMID: 16472381 PMCID: PMC1386651 DOI: 10.1186/1471-2350-7-9] [Citation(s) in RCA: 32] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/21/2005] [Accepted: 02/10/2006] [Indexed: 11/10/2022]
Abstract
Background The prevalence of tobacco usage in Native American adults and adolescents is higher than any other racial or ethnic group, yet biological risk and protective factors underlying tobacco use in this ethnic group remain unknown. A genome scan for loci associated with tobacco use phenotypes was performed with data collected from a community sample of Mission Indians residing in Southwest California. Methods A structured diagnostic interview was used to define two tobacco use phenotypes: 1) any regular tobacco usage (smoked daily for one month or more) and 2) persistent tobacco usage (smoked at least 10 cigarettes a day for more than one year). Heritability was determined and a linkage analysis was performed, using genotypes for a panel 791 microsatellite polymorphisms, for the two phenotypes using variance component methods implemented in SOLAR. Results Analyses of multipoint variance component LOD scores for the two tobacco use phenotypes revealed two scores that exceeded 2.0 for the regular use phenotype: one on chromosomes 6 and one on 8. Four other loci on chromosomes 1,7,13, and 22 were found with LOD scores between 1.0 and 1.5. Two loci of interest were found on chromosomes 1 and 4 for the persistent use phenotype with LOD scores between 1.3–1.5. Bivariate linkage analysis was conducted at the site on chromosome 4 for persistent tobacco use and an alcohol drinking severity phenotype previously identified at this site. The maximum LOD score for the bivariate analysis for the region was 3.4, however, there was insufficient power to exclude coincident linkage. Conclusion While not providing evidence for linkage to specific chromosomal regions these results identify regions of interest in the genome in this Mission Indian population, for tobacco usage, some of which were identified in previous genome scans of non-native populations. Additionally, these data lend support for the hypothesis that cigarette smoking, alcohol dependence and other consumptive behaviors may share some common risk and/or protective factors in this Mission Indian population.
Collapse
Affiliation(s)
- Cindy L Ehlers
- Departments of Molecular and Experimental Medicine, and Neuropharmacology, The Scripps Research Institute, La Jolla California, USA
| | - Kirk C Wilhelmsen
- Departments of Genetics and Neurology, The Carolina Center for Genome Sciences and the Bowles Center for Alcohol Studies, University of North Carolina, North Carolina, USA
| |
Collapse
|
64
|
Ye Y, Zhong X, Zhang H. A genome-wide tree- and forest-based association analysis of comorbidity of alcoholism and smoking. BMC Genet 2005; 6 Suppl 1:S135. [PMID: 16451594 PMCID: PMC1866801 DOI: 10.1186/1471-2156-6-s1-s135] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
Abstract
Genetic mechanisms underlying alcoholism are complex. Understanding the etiology of alcohol dependence and its comorbid conditions such as smoking is important because of the significant health concerns. In this report, we describe a method based on classification trees and deterministic forests for association studies to perform a genome-wide joint association analysis of alcoholism and smoking. This approach is used to analyze the single-nucleotide polymorphism data from the Collaborative Study on the Genetics of Alcoholism in the Genetic Analysis Workshop 14. Our analysis reaffirmed the importance of sex difference in alcoholism. Our analysis also identified genes that were reported in other studies of alcoholism and identified new genes or single-nucleotide polymorphisms that can be useful candidates for future studies.
Collapse
Affiliation(s)
- Yuanqing Ye
- Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT 06520-8034 USA
| | - Xiaoyun Zhong
- Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT 06520-8034 USA
| | - Heping Zhang
- Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT 06520-8034 USA
| |
Collapse
|
65
|
Vink JM, Posthuma D, Neale MC, Eline Slagboom P, Boomsma DI. Genome-wide Linkage Scan to Identify Loci for Age at First Cigarette in Dutch Sibling Pairs. Behav Genet 2005; 36:100-11. [PMID: 16374522 DOI: 10.1007/s10519-005-9012-0] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2005] [Accepted: 07/25/2005] [Indexed: 01/24/2023]
Abstract
The heritability of age at first cigarette was estimated in 5883 Dutch twins and siblings registered with the Netherlands Twin Register. Heritability was 60% for males and 39% for females. Shared environmental influences were found in females only (30%). Linkage analyses were performed on data of 422 DZ twins and siblings from 175 families, forming 368 sibling pairs. Genomic regions that may harbor susceptibility loci for age at first cigarette with LOD score greater than 2 were detected on chromosomes 5, 14 and 22. A simultaneous analysis of these three genomic regions showed that most of the variance was explained by the linkage effect on chromosome 5 (205 cM). This peak encloses the D1A dopamine receptor gene which is a functional candidate gene for smoking behavior.
Collapse
Affiliation(s)
- Jacqueline M Vink
- Department of Biological Psychology, Vrije Universiteit, BT Amsterdam, The Netherlands.
| | | | | | | | | |
Collapse
|
66
|
Morley KI, Medland SE, Ferreira MA, Lynskey MT, Montgomery GW, Heath AC, Madden PA, Martin NG. A Possible Smoking Susceptibility Locus on Chromosome 11p12: Evidence from Sex-limitation Linkage Analyses in a Sample of Australian Twin Families. Behav Genet 2005; 36:87-99. [PMID: 16365831 DOI: 10.1007/s10519-005-9004-0] [Citation(s) in RCA: 32] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2005] [Accepted: 08/04/2005] [Indexed: 12/23/2022]
Abstract
Many twin studies have identified sex differences in the influence of genetic and environmental factors on smoking behaviors. We explore the evidence for sex differences for smoking initiation and cigarette consumption in a sample of Australian twin families, and extend these models to incorporate sex differences in linkage analyses for these traits. We further examine the impact of including or excluding non-smokers in genetic analyses of tobacco consumption. Accounting for sex differences improved linkage results in some instances. We identified one region suggestive of linkage on chromosome 11p12. This locus, as well as another region identified on chromosome 6p12, replicates regions identified in previous studies.
Collapse
Affiliation(s)
- Katherine I Morley
- Genetic Epidemiology, Queensland Institute of Medical Research, PO Royal Brisbane Hospital, Brisbane, Queensland, Australia.
| | | | | | | | | | | | | | | |
Collapse
|
67
|
Beuten J, Ma JZ, Payne TJ, Dupont RT, Quezada P, Huang W, Crews KM, Li MD. Significant association of BDNF haplotypes in European-American male smokers but not in European-American female or African-American smokers. Am J Med Genet B Neuropsychiatr Genet 2005; 139B:73-80. [PMID: 16152573 DOI: 10.1002/ajmg.b.30231] [Citation(s) in RCA: 72] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Brain-derived neurotrophic factor (BDNF) influences dopamine and serotonin neurotransmission in the brain, both of which are involved in the reward system of addiction. The BDNF gene is located in a genomic region on chromosome 11p where we and others have found 'significant' linkage to nicotine dependence (ND). We tested the potential role of variants within BDNF in vulnerability to ND, which was assessed by Smoking Quantity (SQ), the Heaviness of Smoking Index (HSI), and the Fagerström Test for ND (FTND). Six single nucleotide polymorphisms (SNPs) in BDNF were analyzed in an extensively phenotyped cohort of 602 nuclear families with smokers and non-smokers of African-American (AA) or European-American (EA) ancestry. Individual SNP analysis revealed that two SNPs in the pooled male and three SNPs in the EA male samples were significantly associated with at least one adjusted ND measure. However, none of these associations remained significant after correction for multiple testing. Haplotype analysis of rs6484320-rs988748-rs2030324-rs7934165 revealed that a major T-C-T-G haplotype was significantly associated, even after Bonferroni correction, with the three ND measures in the pooled and EA male samples (maximum Z = 3.00, P = 0.002 and maximum Z = 3.13, P = 0.0009 for SQ, respectively). No significant association of a major haplotype with ND was found in the AA or EA female smokers. The significant association of BDNF variants with ND implies that this gene plays a role in the etiology of ND in EAs and that its involvement is gender specific. BDNF may warrant further investigation in ND.
Collapse
Affiliation(s)
- Joke Beuten
- Program in Genomics and Bioinformatics on Drug Addiction, Department of Psychiatry, The University of Texas Health Science Center at San Antonio, San Antonio, Texas
| | | | | | | | | | | | | | | |
Collapse
|
68
|
Gelernter J, Panhuysen C, Weiss R, Brady K, Hesselbrock V, Rounsaville B, Poling J, Wilcox M, Farrer L, Kranzler HR. Genomewide linkage scan for cocaine dependence and related traits: significant linkages for a cocaine-related trait and cocaine-induced paranoia. Am J Med Genet B Neuropsychiatr Genet 2005; 136B:45-52. [PMID: 15909294 DOI: 10.1002/ajmg.b.30189] [Citation(s) in RCA: 111] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
Risk for cocaine dependence (CD) is genetically influenced. We recruited a sample of small nuclear families (528 full and 155 half sibpairs) with at least one subject affected with CD. The sample was classified via Bayesian clustering as 45.5% European American (EA) and 54.5% African American (AA). Assessment, via the Semi-Structured Assessment for Drug Dependence and Alcoholism, allowed for detailed evaluation of substance dependence-related traits. To define subgroups with increased genetic homogeneity, consistent with our a priori analytic plan, we used cluster analytic methods to identify six cocaine-related symptom clusters; membership was shown to be significantly heritable. We then completed a genomewide linkage scan (409 markers) for the CD diagnosis, cocaine-induced paranoia (CIP; an outcome that occurs in some cocaine users) and the clusters (three of which contained >80% of the CD subjects). We observed a "suggestive" linkage signal on chromosome 10 for the trait of CD in the full sample; and two "suggestive" linkage signals at different locations on chromosome 3, in the EA part of the sample. We observed a genomewide-significant lod score of 3.65 for the trait of CIP on chromosome 9, in the AA part of the sample only. Our strongest results were observed for the cluster membership traits, including a lod score of 4.66 for membership in the "Heavy Use, Cocaine Predominant" cluster on chromosome 12 (in EAs only) and a lod score of 3.35 for membership in the "Moderate Cocaine and Opioid Abuse" cluster on chromosome 18. These results provide a basis for the identification of specific genes contributing to risk for these traits.
Collapse
Affiliation(s)
- Joel Gelernter
- Yale University School of Medicine, Department of Psychiatry, Division of Human Genetics; and VA CT Healthcare Center, West Haven, CT 06516, USA.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
69
|
Beuten J, Ma JZ, Payne TJ, Dupont RT, Crews KM, Somes G, Williams NJ, Elston RC, Li MD. Single- and multilocus allelic variants within the GABA(B) receptor subunit 2 (GABAB2) gene are significantly associated with nicotine dependence. Am J Hum Genet 2005; 76:859-64. [PMID: 15759211 PMCID: PMC1199374 DOI: 10.1086/429839] [Citation(s) in RCA: 86] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/15/2004] [Accepted: 02/21/2005] [Indexed: 11/03/2022] Open
Abstract
Twelve single-nucleotide polymorphisms (SNPs) in the human gamma-aminobutyric acid type B (GABA(B)) receptor subunit 2 gene (GABAB2) were tested for association with nicotine dependence (ND) in an extensively phenotyped cohort of 1,276 smokers and nonsmokers, representing approximately 404 nuclear families of African American (AA) or European American (EA) origin. The GABAB2 gene encodes a subunit of the GABA(B) receptor for GABA, an inhibitory neurotransmitter involved in the regulation of many physiological and psychological processes in the brain. The gene is located within a region of chromosome 9q22 that showed a "suggestive" linkage to ND. Individual SNP analysis performed using the PBAT-GEE program indicated that two SNPs in the AAs and four SNPs in the EAs were significantly associated with ND. Haplotype analysis using the Family-Based Association Test revealed that, even after Bonferroni correction, the haplotype C-C-G of rs2491397-rs2184026-rs3750344 had a significant positive association with ND in both the pooled and the AA samples. In the EAs, we identified two haplotypes, C-A-C-A and T-A-T-A, formed by SNPs rs1435252-rs378042-rs2779562-rs3750344, that showed a highly significant negative and positive association with ND, respectively. In summary, our findings provide evidence of a significant association of GABAB2 variants with ND, implying that this gene plays an important role in the etiology of this drug addiction.
Collapse
Affiliation(s)
- Joke Beuten
- Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio; A Comprehensive Tobacco Center, University of Mississippi Medical Center, Jackson, MS; Department of Criminology and Criminal Justice, University of Memphis, and Departments of Preventive Medicine and Dental Hygiene, University of Tennessee Health Science Center, Memphis; and Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland
| | - Jennie Z. Ma
- Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio; A Comprehensive Tobacco Center, University of Mississippi Medical Center, Jackson, MS; Department of Criminology and Criminal Justice, University of Memphis, and Departments of Preventive Medicine and Dental Hygiene, University of Tennessee Health Science Center, Memphis; and Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland
| | - Thomas J. Payne
- Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio; A Comprehensive Tobacco Center, University of Mississippi Medical Center, Jackson, MS; Department of Criminology and Criminal Justice, University of Memphis, and Departments of Preventive Medicine and Dental Hygiene, University of Tennessee Health Science Center, Memphis; and Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland
| | - Randolph T. Dupont
- Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio; A Comprehensive Tobacco Center, University of Mississippi Medical Center, Jackson, MS; Department of Criminology and Criminal Justice, University of Memphis, and Departments of Preventive Medicine and Dental Hygiene, University of Tennessee Health Science Center, Memphis; and Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland
| | - Karen M. Crews
- Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio; A Comprehensive Tobacco Center, University of Mississippi Medical Center, Jackson, MS; Department of Criminology and Criminal Justice, University of Memphis, and Departments of Preventive Medicine and Dental Hygiene, University of Tennessee Health Science Center, Memphis; and Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland
| | - Grant Somes
- Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio; A Comprehensive Tobacco Center, University of Mississippi Medical Center, Jackson, MS; Department of Criminology and Criminal Justice, University of Memphis, and Departments of Preventive Medicine and Dental Hygiene, University of Tennessee Health Science Center, Memphis; and Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland
| | - Nancy J. Williams
- Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio; A Comprehensive Tobacco Center, University of Mississippi Medical Center, Jackson, MS; Department of Criminology and Criminal Justice, University of Memphis, and Departments of Preventive Medicine and Dental Hygiene, University of Tennessee Health Science Center, Memphis; and Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland
| | - Robert C. Elston
- Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio; A Comprehensive Tobacco Center, University of Mississippi Medical Center, Jackson, MS; Department of Criminology and Criminal Justice, University of Memphis, and Departments of Preventive Medicine and Dental Hygiene, University of Tennessee Health Science Center, Memphis; and Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland
| | - Ming D. Li
- Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio; A Comprehensive Tobacco Center, University of Mississippi Medical Center, Jackson, MS; Department of Criminology and Criminal Justice, University of Memphis, and Departments of Preventive Medicine and Dental Hygiene, University of Tennessee Health Science Center, Memphis; and Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland
| |
Collapse
|
70
|
Uhl GR. Molecular genetics of substance abuse vulnerability: remarkable recent convergence of genome scan results. Ann N Y Acad Sci 2005; 1025:1-13. [PMID: 15542694 DOI: 10.1196/annals.1316.001] [Citation(s) in RCA: 59] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
Classical genetic studies document strong complex genetic contributions to abuse of multiple addictive substances. Goals of molecular genetic studies of addiction include: (1) locating chromosomal regions that contain allelic gene variants that contribute to vulnerability to drug dependence and (2) discovering which alleles of which gene markers and which genes provide these enhanced vulnerabilities. Genome scanning provides an approach to these goals. Until recently, data from genome scanning studies did not convincingly identify chromosomal positions for allelic variants predisposing to substance dependence. Nominal results of initial genome scans for alcohol and nicotine dependence failed to display much agreement; no two studies' results seemed to identify the same chromosomal regions for addiction vulnerability alleles. However, recent data from our association-based genome scans for illegal addictions, reanalyses of prior linkage-based results, and data from even newer linkage-based genome scans now provide a striking body of converging results. Sixteen chromosomal regions are identified by reproducible positive results obtained in multiple populations. These 16 regions are thus good candidates to harbor common allelic variants that confer human vulnerability to addiction to several classes of substances. Genomic markers that identify allelic variants that reproducibly alter addiction vulnerability in studies in several populations provide powerful tools for clinical research in addictions and addiction treatments.
Collapse
Affiliation(s)
- George R Uhl
- Molecular Neurobiology Branch, National Institute on Drug Abuse-International Research Program, National Institutes of Health, Baltimore, MD 21224, USA.
| |
Collapse
|